✓
Open
9 Nov 2020
✓
Close
11 Nov 2020
3
Allotment
—
✓
Listing
Fri, Nov 20, 2020
Price Band
₹1490 to ₹1500
Issue Size
4,31,96,968 shares (agg. up to ₹6,480 Cr)
Lot Size
10 Shares
Listing Date
Fri, Nov 20, 2020
Latest GMP
₹118
Est. Gain
7.87%
✦ AI Insight
GMP Trend
18-11-2020₹118Est. ₹1618+7.87%
11-11-2020₹20Est. ₹1520+1.33%
10-11-2020₹25Est. ₹1525+1.67%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 1.72x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Jun 2020 | 31 Mar 2020 | 31 Mar 2019 | 31 Mar 2018 |
|---|---|---|---|---|
| Assets | 4,691.27 | 4,086.04 | 3,523.55 | 2,929.47 |
| Total Income | 916.29 | 2,772.41 | 2,129.77 | 1,671.68 |
| Profit After Tax | 313.59 | 772.86 | 451.86 | 321.05 |
| EBITDA | 444.70 | 1,094.64 | 792.07 | 584.08 |
| NET Worth | 3,963.47 | 3,646.24 | 2,862.00 | 2,410.36 |
| Reserves and Surplus | 3,947.97 | 3,630.74 | 2,846.50 | 2,394.86 |
| Total Borrowing | 4.96 | 4.96 | 5.49 | 5.92 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Chandra Bhagat Pharma Ltd. | SME | ₹10.20 Cr | ₹51 | 51 | ₹51.75 | +1.47% | ₹33.14 (-3.38%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Funding incremental working capital requirements of our Company | 769.50 |
| 2 | Funding capital expenditure requirements of our Company | 168.00 |
| 3 | General corporate purposes | 286.47 |
About Gland Pharma IPO
Gland Pharma Ltd, the Hyderabad-based company is one of the fastest-growing generic injectable companies. It manufactures a diversified range of high-quality complex injectables. The company offers products like sterile injectables, oncology, and ophthalmics, complex injectables (peptides, suspensions, hormonal products, long-acting injectables), NCE-1s, First-to-File products, etc. The company follows a B2B model to sell its products in more than 60 countries including the US, Canada, Australia, India, Europe, etc. Leading pharma companies i.e. Sagent Pharmaceuticals, Apotex Inc. Athnex Pharmaceutical Division, LLC, Fresenius Kabi USA, LLC, etc. are some of the key customers. It has 7 robust manufacturing units in India comprising 4 finished formulations facilities, 22 production lines, and 3 APIs. Company Strengths The extensive product portfolio of complex injectables. Diversified B2B model with a targeted B2C model in India. Strong manufacturing capabilities. Robust financial track record. Experienced and qualified managerial team. + Read More
Contact Details
Gland Pharma Ltd. AddressSy.No.143-148, 150 and 151Near Gandi Maisamma 'X' Roads, D.P.Pally, DundigalMedchal-Malkajgiri, Dist.HyderabadHyderabad, Telangana, 501401+91 40 3051 0999investors@glandpharma.comVisit Website